Nearly a century after The Raman Effect, the scientific ecosystem that discovery helped shape has grown dramatically. Biotechnology, diagnostics, biologics, and pharmaceutical innovation now rely on global networks of researchers,…
The International Conference on Autophagy and Cell Biology (ICACB 2026) brought together cell biologists, bioprocess engineers, and translational researchers around a question that keeps surfacing across disciplines: how much of…
The 26th Indian Veterinary Congress convened at ICAR-IVRI Izatnagar on February 12-13, 2026, with a theme that signals where veterinary science is heading: "Progress and Emerging Trends in Animal Health…
India’s veterinary research ecosystem is rapidly evolving, driven by a growing need for advanced diagnostics, vaccines, and innovation in animal health. At institutions like the Indian Veterinary Research Institute (IVRI) — one…
Choosing an ELISA kit is often treated as a procurement task.In reality, it is a scientific decision with long-term consequences. In bioanalysis, diagnostics, and biosimilar development, the ELISA kit you…
India’s Union Budget 2026–27 introduced a defining initiative for the life sciences sector: Biopharma SHAKTI. More than a funding announcement, Biopharma SHAKTI represents a long-term structural strategy — one aimed at strengthening India’s…
Every mature biotech ecosystem follows a familiar arc. It begins with import dependence — on reagents, assays, instruments, and expertise developed elsewhere. Over time, as scientific capability deepens and regulatory expectations evolve,…
Published by deNOVO Biolabs — Insights from the frontlines of biotech, diagnostics & assay development. Introduction Enzyme-Linked Immunosorbent Assays (ELISAs) are foundational to bioanalytical workflows, especially in pharmacokinetics (PK) studies, immunogenicity…
Republic Day is a time for reflection, not just on national identity, but on what self-reliance truly means for India’s life sciences industry. In the early stages of India’s biotech journey,…
In 2013, a small group of technocrats with deep experience in biotechnology and a shared frustration with a systemic gap in reagent quality came together with a mission: to change…
In the development and manufacture of biologics like monoclonal antibodies, recombinant proteins and vaccines—process-related impurities such as host cell DNA (HCD) and host cell proteins (HCPs) are unavoidable byproducts of the expression system used to…
The life sciences landscape is evolving rapidly.In the next few years, immunology, cell therapy and biosimilars are among the most dynamic sub-sectors shaping the industry.Across global markets, regulatory shifts, technology…
